SCHEMBL11070846

SCHEMBL11070846

CCCCCCCCCCCCCCCCNc1ccc(C(=O)N(C)C)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.53
▸ SCN5A Q14524 2/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ MAOA P21397 1/20 0.53
▸ CNR1 P21554 1/20 0.53
▸ DRD4 P21917 1/20 0.53
▸ ACHE P22303 1/20 0.53
▸ HRH2 P25021 1/20 0.53
▸ HTR2A P28223 1/20 0.53
▸ HTR2C P28335 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ NTSR1 P30989 1/20 0.53
▸ HRH1 P35367 1/20 0.53
▸ DRD3 P35462 1/20 0.53
▸ SCN1A P35498 1/20 0.53
▸ HTR2B P41595 1/20 0.53
▸ SCN7A Q01118 1/20 0.53
▸ SLC6A3 Q01959 1/20 0.53
▸ KCNH2 Q12809 1/20 0.53
▸ SCN9A Q15858 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19149288 0.82 PLK1 (0.52) LMNASCN5ACYP1A2MAOACNR1
SCHEMBL10534588 0.82 HCAR3 (0.59) PLK1PRSS1F2PRSS2PRSS3
SCHEMBL6372015 0.82 PLK1 (0.52) LMNASCN5ACYP1A2MAOACNR1
Cetaben SCHEMBL2112078 0.82 HCAR3 (0.59) PLK1PRSS1F2PRSS2PRSS3
SCHEMBL11478101 0.82 HCAR3 (0.59) PLK1PRSS1F2PRSS2PRSS3
SCHEMBL6372020 0.82 HCAR3 (0.59) PLK1PRSS1F2PRSS2PRSS3
SCHEMBL11283832 0.82 HCAR3 (0.59) PLK1PRSS1F2PRSS2PRSS3
SCHEMBL10950807 0.82 HCAR3 (0.59) PLK1PRSS1F2PRSS2PRSS3
SCHEMBL22398313 0.82 HCAR3 (0.59) PLK1PRSS1F2PRSS2PRSS3
SCHEMBL11278167 0.82 HCAR3 (0.59) PLK1PRSS1F2PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4485105-A Method of treating hyperlipidemia with 4-(monoalkylamino)benzoic acid amides AMERICAN CYANAMID COMPANY (US) 1984-11-27 — — US disclosed
US-4309553-A HYPOLIPIDEMIC, ANTIATHEROSCLEROTIC AMERICAN CYANAMID COMPANY (US) 1982-01-05 — — US disclosed
US-4273785-A ANTILIPEMIC AGENTS, ANTIATHEROSCEROTIC AGENTS AMERICAN CYANAMID COMPANY (US) 1981-06-16 — — US disclosed
US-4242273-A ANTILIPEMIC AND ANTICHOLESTEROL AGENTS AMERICAN CYANAMID COMPANY (US) 1980-12-30 — — US disclosed
US-4136256-A HYPOLIPIDEMIC, ANTIATHEROSCLEROTIC AMERICAN CYANAMID COMPANY (US) 1979-01-23 — — US disclosed
Send feedback